Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Travere Therapeutics Inc (NASDAQ: TVTX) closed at $15.13 in the last session, up 1.24% from day before closing price of $14.94. In other words, the price has increased by $1.24 from its previous closing price. On the day, 0.78 million shares were traded. TVTX stock price reached its highest trading level at $15.15 during the session, while it also had its lowest trading level at $14.71.
Ratios:
We take a closer look at TVTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.03 and its Current Ratio is at 2.05. In the meantime, Its Debt-to-Equity ratio is 12.20 whereas as Long-Term Debt/Eq ratio is at 9.94.
On June 11, 2025, Citigroup reiterated its Buy rating and also upped its target price recommendation from $35 to $32.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 05 ’25 when Cline Christopher R. sold 1,784 shares for $21.05 per share. The transaction valued at 37,553 led to the insider holds 93,126 shares of the business.
Dube Eric M sold 18,924 shares of TVTX for $398,350 on May 05 ’25. The CHIEF EXECUTIVE OFFICER now owns 419,173 shares after completing the transaction at $21.05 per share. On May 05 ’25, another insider, Heerma Peter, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 1,771 shares for $21.05 each. As a result, the insider received 37,280 and left with 128,215 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1343616640 and an Enterprise Value of 1421837952. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.91 while its Price-to-Book (P/B) ratio in mrq is 40.93. Its current Enterprise Value per Revenue stands at 5.198 whereas that against EBITDA is -7.961.
Stock Price History:
The Beta on a monthly basis for TVTX is 0.74, which has changed by 0.84063256 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $25.29, while it has fallen to a 52-week low of $7.72. The 50-Day Moving Average of the stock is -10.44%, while the 200-Day Moving Average is calculated to be -15.28%.
Shares Statistics:
According to the various share statistics, TVTX traded on average about 1.76M shares per day over the past 3-months and 1516630 shares per day over the past 10 days. A total of 88.79M shares are outstanding, with a floating share count of 87.50M. Insiders hold about 1.47% of the company’s shares, while institutions hold 112.64% stake in the company. Shares short for TVTX as of 1749772800 were 10329311 with a Short Ratio of 5.88, compared to 1747267200 on 10434682. Therefore, it implies a Short% of Shares Outstanding of 10329311 and a Short% of Float of 11.709999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
